HK1220691A1 - 用作卵泡刺激素受體調節劑的咪唑化合物及其用途 - Google Patents

用作卵泡刺激素受體調節劑的咪唑化合物及其用途

Info

Publication number
HK1220691A1
HK1220691A1 HK16108822.9A HK16108822A HK1220691A1 HK 1220691 A1 HK1220691 A1 HK 1220691A1 HK 16108822 A HK16108822 A HK 16108822A HK 1220691 A1 HK1220691 A1 HK 1220691A1
Authority
HK
Hong Kong
Prior art keywords
fshr
modulators
imidazole compounds
imidazole
compounds
Prior art date
Application number
HK16108822.9A
Other languages
English (en)
Inventor
‧余
‧理查德森
‧唐納利
‧恩古耶
江旭亮
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1220691A1 publication Critical patent/HK1220691A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK16108822.9A 2013-06-24 2016-07-22 用作卵泡刺激素受體調節劑的咪唑化合物及其用途 HK1220691A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361838502P 2013-06-24 2013-06-24
US201361898611P 2013-11-01 2013-11-01
PCT/US2014/043835 WO2014209978A1 (en) 2013-06-24 2014-06-24 Imidazole compounds as modulators of fshr and uses thereof

Publications (1)

Publication Number Publication Date
HK1220691A1 true HK1220691A1 (zh) 2017-05-12

Family

ID=51177211

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108822.9A HK1220691A1 (zh) 2013-06-24 2016-07-22 用作卵泡刺激素受體調節劑的咪唑化合物及其用途

Country Status (10)

Country Link
US (1) US10138233B2 (zh)
EP (1) EP3013823B1 (zh)
JP (1) JP6523267B2 (zh)
CN (1) CN105658650B (zh)
AU (1) AU2014302710B2 (zh)
CA (1) CA2912918C (zh)
ES (1) ES2657979T3 (zh)
HK (1) HK1220691A1 (zh)
IL (1) IL243223B (zh)
WO (1) WO2014209978A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3129374T (pt) 2014-04-07 2019-03-25 Netherlands Translational Res Center B V (5,6-dihidro)pirimido[4,5-e] indolizinas
WO2015196335A1 (en) 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof
CN106177912B (zh) * 2016-07-18 2019-06-18 暨南大学 Ctrp3蛋白的应用
CN114644641B (zh) * 2020-12-17 2023-04-11 中国科学院广州生物医药与健康研究院 基于螺旋骨架的手性二酚及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3512110B2 (ja) * 1992-02-13 2004-03-29 ファルマシア・アンド・アップジョン・カンパニー ベンゾジアゼピン受容体結合剤として有用な4−オキソ−および4H−イミダゾ(5,1−c)(1,4)ベンゾオキサジン類
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
ATE329911T1 (de) 1998-08-07 2006-07-15 Applied Research Systems Fsh mimetika zur behandlung von infertilität
JP4409680B2 (ja) * 1999-10-18 2010-02-03 株式会社ヤクルト本社 三環性縮合イミダゾール誘導体
WO2002009706A1 (en) 2000-07-27 2002-02-07 Smithkline Beecham Corporation Agonists of follicle stimulating hormone activity
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
PE20060653A1 (es) * 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1
DE602007012473D1 (de) * 2006-12-14 2011-03-24 Vertex Pharma Als proteinkinaseinhibitoren geeignete verbindungen
WO2010025073A1 (en) * 2008-08-28 2010-03-04 Takeda Pharmaceutical Company Limited Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors
EP2361910A4 (en) 2008-10-29 2012-08-01 Taisho Pharmaceutical Co Ltd CONNECTION WITH TAFIA-INHIBITOR EFFECT
TWI461426B (zh) * 2009-05-27 2014-11-21 Merck Sharp & Dohme (二氫)咪唑並異〔5,1-a〕喹啉類
WO2011151361A1 (en) * 2010-06-03 2011-12-08 Glaxo Group Limited Novel compounds
EP2763986B1 (en) * 2011-09-22 2017-06-07 Merck Sharp & Dohme B.V. Fsh receptor antagonists

Also Published As

Publication number Publication date
ES2657979T3 (es) 2018-03-07
AU2014302710B2 (en) 2018-10-04
EP3013823A1 (en) 2016-05-04
US10138233B2 (en) 2018-11-27
IL243223A0 (en) 2016-02-29
JP2016523864A (ja) 2016-08-12
EP3013823B1 (en) 2017-11-01
JP6523267B2 (ja) 2019-05-29
IL243223B (en) 2019-07-31
AU2014302710A1 (en) 2015-12-03
CN105658650A (zh) 2016-06-08
CN105658650B (zh) 2019-01-08
WO2014209978A1 (en) 2014-12-31
CA2912918C (en) 2021-07-27
US20160152609A1 (en) 2016-06-02
CA2912918A1 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
HRP20182004T1 (hr) Tetrahidropiridopirazini modulatori gpr6
IL240736A0 (en) Exciting photo sharing
HK1218757A1 (zh) 用作卵泡刺激素受體調節劑的吡唑化合物及其用途
EP2958897A4 (en) COMPOUNDS USEFUL AS MODULATORS OF TRPM8
HK1208341A1 (zh) 取代的吡唑酮化合物及使用方法
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
EP2971029C0 (en) PRODUCTION OF MALTOOLIGOSACCHARIDES
IL240763A0 (en) The halopyrazoles as thrombin inhibitors
EP3065944A4 (en) Modification of polyamides
HK1220691A1 (zh) 用作卵泡刺激素受體調節劑的咪唑化合物及其用途
EP2974723A4 (en) APPLICATION OF PHTHALIDE COMPOUND
HRP20182110T1 (hr) Sastav spojeva tiakumicina
HK1204916A1 (zh) 淫羊藿苷元的醫藥用途
KR102216470B9 (ko) 천연물 조성물
HK1198422A1 (zh) 羊毛固醇三萜的新穎用途
GB201316438D0 (en) Interconnection of parts
GB201313171D0 (en) Novel use of aggregates